期刊文献+

化疗药物诱发弥漫性肺泡损伤的诊治进展 被引量:2

下载PDF
导出
摘要 肿瘤化疗是肿瘤治疗的重要手段,化疗药物主要通过细胞DNA、蛋白质大分子等发挥作用,在治疗肿瘤的同时,对正常细胞和组织的损伤也是临床关注的重要问题。近年来,随着肿瘤化疗药物的进步和肿瘤治疗经验积累,化疗所致的严重并发症明显减少。肿瘤治疗中化疗引起的肺部并发症病因非常复杂,发病机制多种多样,临床表现急缓各有不同。
出处 《癌症进展》 2009年第1期19-22,共4页 Oncology Progress
  • 相关文献

参考文献17

  • 1Camus P.Drug induced infiltrative lung diseases[M].In:King TE Jr,Schwarz MI (Eds).Interstitial lung disease.4th ed,Hamilton:B C Decker,2003.516
  • 2Inoue A,Saijo Y,Maemondo M,et al.Severe acute interstitial pneumonia and gefitinib[J].Lancet,2003,361:137
  • 3Makris D,Seherpereel A,Copin M C,et al.Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer[J].Cancer,2007,7:150
  • 4Ando M,Okamoto I,Yamamoto N,et al.Readministration of gefitinib in a responder after treatment discontinuation due to gefinitib -related interstitial lung disease:A case report[J].J Clin Oncol,2006,24:2549
  • 5Ortiz LA,Lasky J,Hamiton RFJr,et al.Expression of TNF and the necessity for TNF receptors in bleomycin-induced lunginjury in mice[J].Exp Lung Res,1998,24:721
  • 6Giri SN,Hyde DM,Hollinger,MA.Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice[J].Thorax,1993,48:959
  • 7Piguet PF,Vesin C,Grau GE,et al.Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica[J].Cytokine,1993,5:57
  • 8Nagase T,Uozumi N,Ishii S,et al.A pivotal role of eytosolic phosphelipase A (2) in bleomycin-induced pulmonary fibrosis[J].Nat Med,2002,8:480
  • 9Denholm EM,Phan SH.Bleomycin binding sites on alveolar macrophages[J].J Leukoc Biol,1990,48:519
  • 10Nici L,Santos-Moore A,Kuhn C,et al.Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant arniphostine[J].Cancer,1998,83:2008

同被引文献33

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2陈海英,孔月红,蔡兆明.胸腺细胞的年龄分布及木犀草素对其免疫功能的调节[J].徐州医学院学报,2006,26(4):302-305. 被引量:3
  • 3殷蔚伯,李晔雄,王绿化,等.肿瘤放射治疗手册[M].北京:中国协和医科大学出版社,2011:324-330.
  • 4Barriger RB, Forquer JA, Brabham JG, et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy [ J ]. Int J Radiat Oncol Biol Phys, 2012, 82 ( 1 ) : 457-462.
  • 5Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis[ J]. Acta Oncol,2012,51 (8) :975-983.
  • 6Giroux Leprieur E, Fernandez D, Chatellier G, et al. Non- small cell lung cancer: risk factors of radiation pneumonitis [ J ]. Cancer Radiother, 2012,16 (4) : 257-262.
  • 7Bentzen SM,SKoczylas JZ,Bernier J.Quantitative clinical radiobiology of early and late lung reactions[J].Int J Radiat Boil,2000,76:453.
  • 8Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 9Violet JA,Harme RC.Breast cancer:improving outcome following adjuvant radiotherapy[J].Br J Radiol,2004,77(922):811-820.
  • 10Bentzen SM,Skoczylas JZ,Bernier J.Quantitative clinical radiobiology of early and late lung reactions[J].Int J Radiat Biol,2000,76:453.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部